| | Germany on Monday extended its current pandemic measures as the experts panel appointed by the government has warned the fast spreading Omicron coronavirus variant could bring critical infrastructure in Europe's biggest economy to a breaking point. | | | The U.S. Centers for Disease Control and Prevention (CDC) and State Department on Monday advised against travel to 15 countries and territories, citing a rising number of COVID-19 cases. | | | Even as COVID-19 cases drop and hospitalizations show signs of plateauing in hard-hit pockets of the United States, the still-rising death toll from the Omicron variant highlights the trail of loss that follows every virus surge. | | | COVID-19 contributed to the biggest annual reduction in life expectancy on record in Canada in 2020, the first year of the pandemic, Statistics Canada said in preliminary findings released on Monday. | | | The U.S. Food and Drug Administration (FDA) is likely to restrict the use of COVID-19 antibody treatments from Regeneron and Eli Lilly as they are ineffective against the Omicron variant, the Washington Post reported on Monday. | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | Almost 400 people in France who were hospitalised due to a COVID-19 infection died over the past 24 hours, official data showed on Monday, a value not seen since April. | | | Chile, which already boasts one of the world's highest COVID-19 vaccination rates, has agreed to purchase 2 million vaccine doses from Moderna Inc , Chilean interim health minister Maria Teresa Valenzuela said on Monday. | | | Norway will end its system of mandatory COVID-19 quarantines for non-vaccinated travellers and close contacts of infected persons, replacing it instead with a daily test regime, the government announced on Monday. | | | An influential consumer advocacy group is pressing Pfizer Inc to supply more of its new COVID-19 pill Paxlovid to developing countries this year, concerned that access to the treatment will mirror inequalities in vaccines. | | | | |